Celling Biosciences Competitors and Similar CompaniesClear all
Celling Biosciences's competitors and similar companies include PerSys Medical, Orthocell, InGeneron, Celldex Therapeutics and Stemgenn.
 Celling Biosciences Celling Biosciences is a company developing point-of-care systems, surgical techniques, and technology platforms that create the optimal environment for regenerative cell therapies. |  Orthocell Orthocell is a company that develops devices for regenerating mobility of tendon, cartilage, and soft tissue. |  InGeneron InGeneron is a cell therapy company that offers treatments designed to heal certain chronic conditions using a patient’s own regenerative cells. |  Celldex Therapeutics Celldex Therapeutics (formerly Avant Immunotherapeutics) is a biopharmaceutical company that specializes in monoclonal and bispecific antibodies development. | |||
Founding Date | Founding Date 2013 | Founding Date 1988 | Founding Date 2006 | Founding Date 2006 | Founding Date 1983 | Founding Date 2014 |
Type | Type Private | Type Private | Type Public | Type Private | Type Public | Type Private |
Tags | ||||||
Locations | Locations Austin, US HQ Curitiba, BR Dubai, AE | Locations Houston, US HQ | Locations Murdoch, AU HQ | Locations Houston, US HQ München, DE | Locations Hampton, US HQ Fall River, US Needham, US New Haven, US | Locations New Delhi, IN HQ |
Employees | Employees 47 | Employees 20 | Employees N/A | Employees 16 | Employees 1608% increase | Employees 9 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 65.5 m | Valuation ($) N/A | Valuation ($) 1.9 b | Valuation ($) N/A |
Financial | ||||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $7.6m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $1.5m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $2.2m (FY, 2025) | Cost of goods N/A | Cost of goods $200k (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $5.7m (FY, 2025) | Gross profit N/A | Gross profit $1.3m (FY, 2025) | Gross profit N/A |
Net income | Net income N/A | Net income N/A | Net income ($8.6m) (FY, 2025) | Net income N/A | Net income ($258.8m) (FY, 2025) | Net income N/A |
Funding | ||||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 47.5m | Total funding raised $ 2m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
PerSys Medical
HQ
Houston, US
Employees
20
PerSys Medical is a company that provides emergency medical devices.
View companyOrthocell
HQ
Murdoch, AU
Orthocell is a company that develops devices for regenerating mobility of tendon, cartilage, and soft tissue.
View companyInGeneron
HQ
Houston, US
Employees
16
InGeneron is a cell therapy company that offers treatments designed to heal certain chronic conditions using a patient’s own regenerative cells.
View companyCelldex Therapeutics
HQ
Hampton, US
Employees
160↑ 8% increase
Celldex Therapeutics (formerly Avant Immunotherapeutics) is a biopharmaceutical company that specializes in monoclonal and bispecific antibodies development.
View company